Gaithersburg-based molecular diagnostics company OpGen Inc. went public Tuesday, and saw its shares drop more than 20 percent during the day before closing at $4.85, down nearly 19 percent.
CEO Evan Jones said he's not concerned. In the world of biotech, making money can take time.